Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings
Latest Information Update: 23 May 2025
At a glance
- Drugs Nirmatrelvir+ritonavir (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms CanTreatCOVID
Most Recent Events
- 16 May 2025 Protocol was amended to remove 1 arm "Other Emerging Interventions".
- 16 May 2025 Planned End Date changed from 31 Mar 2026 to 28 Jun 2025.
- 16 May 2025 Status changed from recruiting to active, no longer recruiting.